The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Treating insulin resistance in hypertension with metformin reduces both blood pressure and metabolic risk factors
Abstract
Insulin resistance and hyperinsulinaemia may play an important role in both the development of hypertension and its accompanying metabolic aberrations. In order to investigate this possibility, nine non‐obese, non‐diabetic, non‐smoking, middle‐aged men with untreated hypertension were treated with metformin 850 mg b.i.d. for 6 weeks as a pilot study and within‐patient comparison. Metformin decreased total and LDL‐cholesterol (P< 0.01), triglyceride (P< 0.01), fasting plasma insulin (P< 0.01) and C‐peptide levels (P< 0.02). Glucose disposal, an indicator of insulin action measured by means of the euglycaemic clamp technique, increased (P< 0.001). Tissue plasminogen activator (t‐PA) activity increased (P< 0.02), and t‐PA antigen decreased (P< 0.01), whereas plasminogen activator inhibitor (PAI‐1) and fibrinogen were unaffected by metformin treatment. Body weight remained unchanged. Withdrawal of metformin was associated with the return of both blood pressure and metabolism towards the initial levels. In conclusion, metformin treatment increased insulin action, lowered blood pressure, improved the metabolic risk factor profile and tended to increase the fibrinolytic activity in these mildly hypertensive subjects. These results support the view that insulin resistance plays a role in hypertension, and may open up a new field for the alleviation of abnormalities associated with cardiovascular disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Insulin Resistance in Essential Hypertension
Ferrannini, E., Buzzigoli, G., Bonadonna, R., Giorico, M. A., Oleggini, M., Graziadei, L., Pedrinelli, R., Brandi, L., & Bevilacqua, S. (1987) · New England Journal of Medicine · doi:10.1056/nejm198708063170605 · Cited by 2,344
Insulin resistance is a characteristic feature of primary hypertension independent of obesity
Pollare, T., Lithell, H., & Berne, C. (1990) · Metabolism · doi:10.1016/0026-0495(90)90071-j · Cited by 530
Cited by
Efficacy of Metformin in Patients with Non-Insulin-Dependent Diabetes Mellitus
DeFronzo, R. A., & Goodman, A. M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508313330902 · Cited by 1,368
Kirpichnikov, D., McFarlane, S. I., & Sowers, J. R. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-1-200207020-00009 · Cited by 1,084
Velazquez, E. M., Mendoza, S., Hamer, T., Sosa, F., & Glueck, C. J. (1994) · Metabolism · doi:10.1016/0026-0495(94)90209-7 · Cited by 865
(1999) · Diabetes Care · doi:10.2337/diacare.22.4.623 · Cited by 725
Improved Endothelial Function With Metformin in Type 2 Diabetes Mellitus
Mather, K. J., Verma, S., & Anderson, T. J. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01129-9 · Cited by 513
Metadata
- Authors
- LANDIN, K., TENGBORN, L., & SMITH, U.
- Venue
- Journal of Internal Medicine
- Publisher
- Wiley
- Published
- 1991-02
- Volume
- 229
- Issue
- 2
- Pages
- 181-187
- ISSN
- 0954-6820 (ISSN-L)
- 1365-2796
- OpenAlex
- W1997037157
- Cited by
- 225
- References
- 2
- FWCI
- 9.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treating insulin resistance in hypertension with metformin reduces both blood pressure and metabolic risk factors. https://app.cochat.ai/papers/10.1111/j.1365-2796.1991.tb00328.x
- The paper
- LANDIN, K., TENGBORN, L., & SMITH, U. (1991). Treating insulin resistance in hypertension with metformin reduces both blood pressure and metabolic risk factors. Journal of Internal Medicine. https://doi.org/10.1111/j.1365-2796.1991.tb00328.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.